Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia.

Whiting JH, Korzenik JR, Miller FJ, Pollack JS, White RI. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol. 2000 Jul-Aug; 11(7):855-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.